Ramasastry Saira — SEC insider filings
SEC reporting owner CIK 1547959. 40 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-10-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 19 filings — 97,367 shares, $3,634,101 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 82.
- Largest priced transaction: sale of 10,000 shares @ $43.73 ($437,275) in Vir Biotechnology, Inc., filed 2021-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Director | 16 | — | 14 legs · 53,180 sh · $2,608,383 | 34 |
| Vir Biotechnology, Inc. (VIR) | Director | 10 | — | 5 legs · 24,187 sh · $761,094 | 15 |
| SANGAMO THERAPEUTICS, INC (SGMO) | Director | 3 | — | 1 leg · 10,000 sh · $132,747 | 6 |
| Day One Biopharmaceuticals, Inc. (DAWN) | Director | 7 | — | 1 leg · 10,000 sh · $131,877 | 23 |
| Akouos, Inc. (AKUS) | Director | 3 | — | — | 3 |
| Sensei Biotherapeutics, Inc. (FTH) | Director | 1 | — | — | 1 |
Insider filings — Ramasastry Saira
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $28.97 · Sale (S): 2,000 @ $92.28 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Sensei Biotherapeutics, Inc. (FTH) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 3,977 · Sale (S): 3,977 @ $100 · Option exercise (M): 3,977 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $109.47 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 40,485 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 47,581 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 more | EDGAR |
| 2026-04-16 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $96.90 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $90.76 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $102.09 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $90.99 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,000 @ $23.51 · Sale (S): 5,000 @ $80 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 2,000 @ $23.51 · Sale (S): 1,000 @ $69.46 · Sale (S): 1,000 @ $70 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 47,581 (derivative) @ $0 · Grant/award (A): 47,581 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 more | EDGAR |
| 2025-09-10 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 17,000 @ $23.51 · Sale (S): 17,000 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale (S): 5,703 @ $46.20 · Option exercise (M): 2,500 @ $14.12 · Sale (S): 2,500 @ $45.74 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,703 · Option exercise (M): 5,703 (derivative) @ $0 · Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Sale (S): 10,000 @ $13.19 | EDGAR |
| 2024-06-12 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 4,000 @ $10.95 | EDGAR |
| 2024-06-07 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Option exercise (M): 5,000 @ $14.12 · Sale (S): 5,000 @ $25.68 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
| 2023-06-26 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 3,500 @ $25.67 | EDGAR |
| 2023-05-24 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 6,027 @ $0 · Grant/award (A): 12,054 (derivative) @ $0 | EDGAR |
| 2022-12-02 | 4 | Akouos, Inc. (AKUS) | Disposition to issuer (D): 16,000 (derivative) | EDGAR |
| 2022-07-13 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 5,000 @ $12.76 · Sale (S): 5,000 @ $30 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2022-06-27 | 4 | Akouos, Inc. (AKUS) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 28,700 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 6,405 @ $0 · Sale (S): 1,687 @ $23.82 · Grant/award (A): 12,810 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Akouos, Inc. (AKUS) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2021-05-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 3,374 @ $0 · Grant/award (A): 6,748 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | Vir Biotechnology, Inc. (VIR) | Option exercise (M): 10,000 @ $12.76 · Sale (S): 10,000 @ $43.73 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/award (A): 8,200 @ $0 · Grant/award (A): 16,400 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | SANGAMO THERAPEUTICS, INC (SGMO) | Option exercise (M): 10,000 @ $5.99 · Sale (S): 10,000 @ $13.27 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4/A | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 24,497 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1547959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs